Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free PACS Stock Alerts

PACS Group (PACS) Financials

PACS Group logo
$36.62 -1.38 (-3.63%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$37.24 +0.61 (+1.67%)
As of 05/29/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for PACS Group

Annual Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 150 113 56 192
Consolidated Net Income / (Loss)		 150 113 55 191
Net Income / (Loss) Continuing Operations		 150 113 55 191
Total Pre-Tax Income 		207 157 102 284
Total Operating Income		 229 208 123 310
Total Gross Profit		 561 664 793 1,159
Total Revenue		 2,422 3,111 4,090 5,289
Operating Revenue		 2,422 3,111 4,090 5,289
Total Cost of Revenue		 1,861 2,448 3,297 4,130
Operating Cost of Revenue		 1,861 2,448 3,297 4,130
Total Operating Expenses		 331 456 670 850
Selling, General & Admin Expense		 149 214 344 415
Depreciation Expense		 22 26 41 56
Other Operating Expenses / (Income)		 160 217 285 379
Total Other Income / (Expense), net		 -22 -50 -22 -25
Interest Expense		 26 50 44 28
Other Income / (Expense), net		 3.22 -0.54 23 3.22
Income Tax Expense		 57 44 46 93
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.01 -0.42 -0.08
Basic Earnings per Share		 $1.17 $0.88 $0.38 $1.23
Weighted Average Basic Shares Outstanding		 128.72M 128.72M 146.66M 156.18M
Diluted Earnings per Share		 $1.17 $0.88 $0.38 $1.22
Weighted Average Diluted Shares Outstanding		 128.72M 128.72M 148.57M 156.70M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 157.17M

Quarterly Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 20 34 35 -32 16 37 28 51 52 60 81
Consolidated Net Income / (Loss)		 20 34 35 -32 16 36 28 51 52 60 81
Net Income / (Loss) Continuing Operations		 20 34 35 -32 16 36 28 51 52 60 81
Total Pre-Tax Income 		27 49 58 -51 34 61 43 79 76 87 114
Total Operating Income		 36 63 65 -37 23 72 48 80 86 95 120
Total Gross Profit		 151 174 184 174 177 259 253 288 298 319 346
Total Revenue		 789 853 920 936 1,026 1,208 1,277 1,309 1,345 1,358 1,420
Operating Revenue		 789 853 920 936 1,026 1,208 1,277 1,309 1,345 1,358 1,420
Total Cost of Revenue		 638 680 736 762 850 949 1,024 1,021 1,046 1,039 1,075
Operating Cost of Revenue		 638 680 736 762 850 949 1,024 1,021 1,046 1,039 1,075
Total Operating Expenses		 114 111 119 211 154 187 205 208 212 225 226
Selling, General & Admin Expense		 50 42 47 137 71 90 99 100 103 113 112
Depreciation Expense		 6.36 7.28 8.12 9.25 11 13 13 13 14 15 18
Other Operating Expenses / (Income)		 58 62 64 65 73 84 94 94 95 96 96
Total Other Income / (Expense), net		 -9.01 -13 -7.61 -14 11 -11 -5.41 -1.89 -9.97 -7.88 -6.30
Interest Expense		 10 14 16 9.92 9.03 9.30 6.90 4.35 8.53 8.58 6.42
Other Income / (Expense), net		 1.21 0.46 8.49 -3.91 20 -1.48 1.49 2.47 -1.44 0.70 0.13
Income Tax Expense		 7.47 15 23 -19 17 25 14 28 24 27 33
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 0.00 0.00 0.59 -1.01 -0.09 0.00 -0.08 0.08 -0.03
Basic Earnings per Share		 $0.15 $0.28 $0.27 ($0.21) $0.10 $0.22 $0.18 $0.33 $0.33 $0.39 $0.51
Weighted Average Basic Shares Outstanding		 128.72M 128.72M 128.72M 149.46M 153.12M 146.66M 155.18M 156.34M 156.58M 156.18M 157.07M
Diluted Earnings per Share		 $0.15 $0.28 $0.27 ($0.21) $0.10 $0.22 $0.17 $0.31 $0.32 $0.42 $0.50
Weighted Average Diluted Shares Outstanding		 128.72M 128.72M 128.72M 149.46M 158.45M 148.57M 166.42M 165.47M 164.71M 156.70M 162.08M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 24.64M 152.40M - 0.00 - - 156.62M 157.17M 158.27M

Annual Cash Flow Statements for PACS Group

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 30 20 42 71
Net Cash From Operating Activities		 93 64 367 404
Net Cash From Continuing Operating Activities		 93 64 367 404
Net Income / (Loss) Continuing Operations		 150 113 55 191
Consolidated Net Income / (Loss)		 150 113 55 191
Depreciation Expense		 22 26 41 56
Amortization Expense		 1.21 6.07 3.12 3.15
Non-Cash Adjustments To Reconcile Net Income		 15 21 133 97
Changes in Operating Assets and Liabilities, net		 -96 -102 135 57
Net Cash From Investing Activities		 -75 -173 -443 -264
Net Cash From Continuing Investing Activities		 -75 -173 -443 -264
Purchase of Property, Plant & Equipment		 -78 -173 -350 -249
Acquisitions		 0.00 -2.60 -33 0.00
Purchase of Investments		 0.00 0.00 -91 -21
Sale of Property, Plant & Equipment		 0.01 0.75 1.50 0.75
Sale and/or Maturity of Investments		 0.00 0.00 26 0.00
Other Investing Activities, net		 - 1.86 3.52 5.59
Net Cash From Financing Activities		 12 130 117 -69
Net Cash From Continuing Financing Activities		 12 130 117 -69
Repayment of Debt		 -173 -1,058 -1,073 -60
Payment of Dividends		 -60 -80 -34 -0.38
Issuance of Debt		 242 1,267 748 0.00
Issuance of Common Equity		 3.25 0.59 510 0.00
Other Financing Activities, net		 0.00 0.00 -34 -8.40
Cash Interest Paid		 26 51 48 41
Cash Income Taxes Paid		 43 60 108 84

Quarterly Cash Flow Statements for PACS Group

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q4 2025 Q1 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 37 -54 9.63 29 -25 -15 -16 99 130 -127 42
Net Cash From Operating Activities		 79 -21 15 -9.70 59 35 209 65 150 -3.39 236
Net Cash From Continuing Operating Activities		 79 -21 15 -9.70 59 35 209 65 150 -3.39 236
Net Income / (Loss) Continuing Operations		 38 21 20 34 35 -11 -19 36 28 60 81
Consolidated Net Income / (Loss)		 38 21 20 34 35 -11 -19 36 28 60 81
Depreciation Expense		 5.83 6.16 6.36 7.28 8.12 8.78 11 13 13 15 18
Amortization Expense		 0.62 3.66 0.55 1.24 0.78 0.78 0.78 0.78 0.79 0.79 0.79
Non-Cash Adjustments To Reconcile Net Income		 3.98 4.31 6.08 6.74 6.86 102 27 26 24 26 31
Changes in Operating Assets and Liabilities, net		 31 -56 -18 -59 8.18 -65 189 -11 85 -106 106
Net Cash From Investing Activities		 -58 -9.71 -46 -60 -119 -121 -99 -104 -16 -118 -127
Net Cash From Continuing Investing Activities		 -58 -9.71 -46 -60 -119 -121 -99 -104 -16 -118 -127
Purchase of Property, Plant & Equipment		 -58 -11 -46 -58 -89 -111 -66 -83 -18 -114 -108
Purchase of Investments		 0.00 - - - -25 -10 -10 -46 0.00 -6.05 -20
Divestitures		 - - - - 0.67 - - 1.31 1.30 - 1.44
Net Cash From Financing Activities		 15 -24 40 98 34 71 -126 139 -4.07 -5.47 -68
Net Cash From Continuing Financing Activities		 15 -24 40 98 34 71 -126 139 -4.07 -5.47 -68
Repayment of Debt		 -44 -415 -100 -498 -105 -465 -366 -138 -4.07 -5.47 -101
Payment of Dividends		 -19 -25 -25 -11 -17 -16 - - 0.00 0.00 -0.21
Issuance of Debt		 78 416 165 608 157 171 144 276 0.00 - 45
Other Financing Activities, net		 - - - - - - - 0.00 0.00 - -11
Cash Interest Paid		 9.93 18 7.39 15 16 9.91 14 8.90 8.09 12 9.10
Cash Income Taxes Paid		 0.00 17 35 8.17 0.00 43 34 30 0.36 3.00 0.33

Annual Balance Sheets for PACS Group

This table presents PACS Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 3,513 5,243 5,584
Total Current Assets		 722 938 1,070
Cash & Equivalents		 73 158 197
Accounts Receivable		 600 717 702
Prepaid Expenses		 49 64 171
Plant, Property, & Equipment, net		 578 991 1,201
Total Noncurrent Assets		 2,213 3,314 3,313
Goodwill		 65 67 68
Other Noncurrent Operating Assets		 2,148 3,247 3,245
Total Liabilities & Shareholders' Equity		 3,513 5,243 5,584
Total Liabilities		 3,411 4,527 4,632
Total Current Liabilities		 457 978 1,001
Short-Term Debt		 17 157 4.46
Accounts Payable		 141 175 192
Accrued Expenses		 70 142 154
Current Employee Benefit Liabilities		 92 146 188
Other Current Liabilities		 137 358 463
Total Noncurrent Liabilities		 2,954 3,549 3,630
Long-Term Debt		 716 251 345
Asset Retirement Reserve & Litigation Obligation		 146 165 193
Other Noncurrent Operating Liabilities		 2,092 3,133 3,093
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 102 716 952
Total Preferred & Common Equity		 96 710 947
Total Common Equity		 96 710 947
Common Stock		 0.13 592 637
Retained Earnings		 96 118 310
Noncontrolling Interest		 5.60 6.14 5.68

Quarterly Balance Sheets for PACS Group

This table presents PACS Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 3,861 3,933 4,517 5,494 5,502 5,627 5,664
Total Current Assets		 821 764 735 1,081 1,077 1,127 1,068
Cash & Equivalents		 81 73 50 288 294 356 248
Accounts Receivable		 678 631 624 742 690 695 733
Prepaid Expenses		 62 60 61 52 93 76 87
Plant, Property, & Equipment, net		 667 857 925 999 1,032 0.00 1,308
Total Noncurrent Assets		 2,373 2,312 2,857 3,414 3,392 4,500 3,287
Goodwill		 65 65 65 67 67 68 68
Other Noncurrent Operating Assets		 2,308 2,247 2,792 3,347 3,325 4,432 3,219
Total Liabilities & Shareholders' Equity		 3,861 3,933 4,517 5,494 5,502 5,627 5,664
Total Liabilities		 3,741 3,390 3,850 4,738 4,690 4,750 4,621
Total Current Liabilities		 535 488 682 1,107 1,167 1,198 1,074
Short-Term Debt		 17 16 16 155 152 107 8.39
Accounts Payable		 157 126 155 199 172 205 181
Accrued Expenses		 71 75 107 164 248 179 168
Current Employee Benefit Liabilities		 144 99 155 210 193 253 243
Other Current Liabilities		 147 172 249 379 402 453 473
Total Noncurrent Liabilities		 2,662 2,647 3,168 3,631 3,522 3,552 3,548
Long-Term Debt		 231 227 254 249 247 246 285
Asset Retirement Reserve & Litigation Obligation		 155 172 188 187 208 177 209
Other Noncurrent Operating Liabilities		 2,276 2,248 2,726 3,195 3,068 3,129 3,054
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 119 543 667 756 813 877 1,042
Total Preferred & Common Equity		 114 537 660 750 807 871 1,037
Total Common Equity		 113 537 660 750 807 871 1,037
Common Stock		 0.13 472 579 604 609 621 647
Retained Earnings		 113 65 81 147 197 250 390
Noncontrolling Interest		 5.60 6.11 6.70 6.05 5.83 5.59 5.02

Annual Metrics And Ratios for PACS Group

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 28.47% 31.44% 29.32%
EBITDA Growth		 0.00% -6.70% -20.56% 95.78%
EBIT Growth		 0.00% -10.90% -29.60% 114.41%
NOPAT Growth		 0.00% -10.58% -55.01% 210.69%
Net Income Growth		 0.00% -24.99% -50.97% 245.95%
EPS Growth		 0.00% -24.79% -56.82% 221.05%
Operating Cash Flow Growth		 0.00% -31.22% 476.70% 10.04%
Free Cash Flow Firm Growth		 0.00% 0.00% 77.45% 150.41%
Invested Capital Growth		 0.00% 0.00% 26.95% 14.38%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - -
Gross Margin		 23.15% 21.33% 19.38% 21.92%
EBITDA Margin		 10.57% 7.68% 4.64% 7.03%
Operating Margin		 9.47% 6.68% 3.01% 5.85%
EBIT Margin		 9.60% 6.66% 3.57% 5.91%
Profit (Net Income) Margin		 6.21% 3.63% 1.35% 3.62%
Tax Burden Percent		 72.69% 71.75% 54.50% 67.31%
Interest Burden Percent		 89.02% 75.91% 69.61% 90.93%
Effective Tax Rate		 27.31% 28.25% 45.50% 32.69%
Return on Invested Capital (ROIC)		 0.00% 39.19% 7.77% 20.13%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 28.20% 5.19% 11.72%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 182.74% 5.77% 2.83%
Return on Equity (ROE)		 0.00% 221.93% 13.54% 22.96%
Cash Return on Invested Capital (CROIC)		 0.00% -160.81% -15.98% 6.72%
Operating Return on Assets (OROA)		 0.00% 5.90% 3.33% 5.78%
Return on Assets (ROA)		 0.00% 3.21% 1.26% 3.54%
Return on Common Equity (ROCE)		 0.00% 209.72% 13.35% 22.79%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 167 149 67 208
NOPAT Margin		 6.88% 4.79% 1.64% 3.94%
Net Nonoperating Expense Percent (NNEP)		 0.00% 10.99% 2.58% 8.41%
Return On Investment Capital (ROIC_SIMPLE)		 - 17.87% 5.97% 16.01%
Cost of Revenue to Revenue		 76.85% 78.67% 80.62% 78.08%
SG&A Expenses to Revenue		 6.15% 6.87% 8.41% 7.85%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 13.68% 14.66% 16.37% 16.06%
Earnings before Interest and Taxes (EBIT)		 233 207 146 313
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 256 239 190 372
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 4.68 2.82 6.35
Price to Tangible Book Value (P/TBV)		 0.00 14.59 3.11 6.84
Price to Revenue (P/Rev)		 0.19 0.14 0.49 1.14
Price to Earnings (P/E)		 2.99 3.99 35.83 31.39
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 33.44% 25.08% 2.79% 3.19%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.47 2.33 5.59
Enterprise Value to Revenue (EV/Rev)		 0.00 0.36 0.55 1.17
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 4.67 11.88 16.60
Enterprise Value to EBIT (EV/EBIT)		 0.00 5.38 15.45 19.73
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 7.48 33.61 29.61
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 17.50 6.14 15.26
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 88.73
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 7.20 0.57 0.37
Long-Term Debt to Equity		 0.00 7.04 0.35 0.36
Financial Leverage		 0.00 6.48 1.11 0.24
Leverage Ratio		 0.00 34.53 10.71 6.49
Compound Leverage Factor		 0.00 26.21 7.46 5.90
Debt to Total Capital		 0.00% 87.81% 36.30% 26.83%
Short-Term Debt to Total Capital		 0.00% 2.02% 13.96% 0.34%
Long-Term Debt to Total Capital		 0.00% 85.79% 22.34% 26.49%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.67% 0.55% 0.44%
Common Equity to Total Capital		 0.00% 11.52% 63.15% 72.73%
Debt to EBITDA		 0.00 3.07 2.15 0.94
Net Debt to EBITDA		 0.00 2.76 1.32 0.41
Long-Term Debt to EBITDA		 0.00 3.00 1.32 0.93
Debt to NOPAT		 0.00 4.91 6.08 1.68
Net Debt to NOPAT		 0.00 4.42 3.73 0.73
Long-Term Debt to NOPAT		 0.00 4.80 3.74 1.65
Altman Z-Score		 0.00 1.29 1.16 2.00
Noncontrolling Interest Sharing Ratio		 0.00% 5.51% 1.44% 0.71%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 1.58 0.96 1.07
Quick Ratio		 0.00 1.47 0.89 0.90
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -612 -138 70
Operating Cash Flow to CapEx		 118.39% 37.02% 105.46% 162.73%
Free Cash Flow to Firm to Interest Expense		 0.00 -12.25 -3.11 2.45
Operating Cash Flow to Interest Expense		 3.63 1.28 8.28 14.25
Operating Cash Flow Less CapEx to Interest Expense		 0.56 -2.17 0.43 5.49
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.89 0.93 0.98
Accounts Receivable Turnover		 0.00 5.19 6.21 7.46
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 5.39 0.00 4.83
Accounts Payable Turnover		 0.00 17.37 20.87 22.49
Days Sales Outstanding (DSO)		 0.00 70.39 58.75 48.95
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 21.02 17.49 16.23
Cash Conversion Cycle (CCC)		 0.00 49.37 41.26 32.72
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 761 966 1,105
Invested Capital Turnover		 0.00 8.18 4.74 5.11
Increase / (Decrease) in Invested Capital		 0.00 761 205 139
Enterprise Value (EV)		 0.00 1,115 2,254 6,170
Market Capitalization		 450 450 1,998 6,012
Book Value per Share		 $0.00 $0.75 $4.66 $6.05
Tangible Book Value per Share		 $0.00 $0.24 $4.22 $5.61
Total Capital		 0.00 834 1,124 1,302
Total Debt		 0.00 733 408 349
Total Long-Term Debt		 0.00 716 251 345
Net Debt		 0.00 659 250 152
Capital Expenditures (CapEx)		 78 172 348 248
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 209 -41 -124
Debt-free Net Working Capital (DFNWC)		 0.00 282 117 73
Net Working Capital (NWC)		 0.00 265 -40 68
Net Nonoperating Expense (NNE)		 16 36 12 17
Net Nonoperating Obligations (NNO)		 0.00 659 250 152
Total Depreciation and Amortization (D&A)		 24 32 44 59
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 6.71% -1.00% -2.35%
Debt-free Net Working Capital to Revenue		 0.00% 9.06% 2.85% 1.38%
Net Working Capital to Revenue		 0.00% 8.52% -0.98% 1.29%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.38 $1.23
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 146.66M 156.18M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.38 $1.22
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 148.57M 156.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 157.17M
Normalized Net Operating Profit after Tax (NOPAT)		 167 149 67 208
Normalized NOPAT Margin		 6.88% 4.79% 1.64% 3.94%
Pre Tax Income Margin		 8.55% 5.06% 2.48% 5.38%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 9.11 4.15 3.29 11.03
NOPAT to Interest Expense		 6.53 2.99 1.51 7.35
EBIT Less CapEx to Interest Expense		 6.04 0.70 -4.56 2.27
NOPAT Less CapEx to Interest Expense		 3.47 -0.46 -6.34 -1.41
Payout Ratios		 - - - -
Dividend Payout Ratio		 40.05% 71.22% 60.93% 0.20%
Augmented Payout Ratio		 40.05% 71.22% 60.93% 0.20%

Quarterly Metrics And Ratios for PACS Group

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 157,165,029.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 157,165,029.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.51
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 31.94% 29.08% 0.00% 0.00% 38.85% 39.92% 31.01% 12.43% 11.22%
EBITDA Growth		 0.00% 0.00% 46.76% -88.79% 0.00% 0.00% -23.66% 411.75% 81.46% 32.49% 120.23%
EBIT Growth		 0.00% 0.00% 48.06% -106.81% 0.00% 0.00% -32.74% 301.94% 98.72% 35.30% 142.09%
NOPAT Growth		 0.00% 0.00% 18.45% -98.51% 0.00% 0.00% -18.87% 300.53% 434.98% 53.19% 166.27%
Net Income Growth		 0.00% 0.00% 30.70% -151.40% 0.00% 0.00% -18.49% 259.89% 222.83% 65.19% 184.24%
EPS Growth		 0.00% 0.00% 31.03% -143.75% 0.00% 0.00% -37.04% 247.62% 220.00% 90.91% 194.12%
Operating Cash Flow Growth		 0.00% 0.00% -25.86% 265.16% 0.00% 0.00% 155.73% 0.00% 0.00% -105.25% 57.30%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 98.56% 110.24% 0.00% 54.67% -1,040.96%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.22% -5.12% 0.00% 14.38% 24.59%
Revenue Q/Q Growth		 3.75% 8.11% 0.00% 5.04% 4.53% 17.69% 0.00% 0.00% 0.00% 1.00% 4.60%
EBITDA Q/Q Growth		 -21.50% 60.61% 0.00% -93.45% 760.19% 53.98% 0.00% 0.00% 0.00% 12.42% 24.62%
EBIT Q/Q Growth		 -19.80% 67.48% 0.00% -103.61% 1,435.99% 65.16% 0.00% 0.00% 0.00% 12.45% 25.97%
NOPAT Q/Q Growth		 -20.43% 63.76% 0.00% -99.08% 2,125.42% 284.86% 0.00% 0.00% 0.00% 10.20% 30.56%
Net Income Q/Q Growth		 -6.09% 71.31% 0.00% -122.20% 248.61% 123.26% 0.00% 0.00% 0.00% 14.25% 34.93%
EPS Q/Q Growth		 -6.25% 86.67% 0.00% -118.42% 242.86% 120.00% 0.00% 0.00% 0.00% 31.25% 19.05%
Operating Cash Flow Q/Q Growth		 172.05% -163.88% 0.00% -40.78% 500.78% -69.12% 0.00% 0.00% 0.00% 0.00% 7,071.53%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -27.06% 100.00% 0.00% 0.00% 0.00% 0.00% 90.97% -75.81%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 18.95% -100.00% 0.00% 0.00% 0.00% 0.00% 26.31% -1.57%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 19.10% 20.34% 21.26% 22.38% 17.22% 21.40% 19.84% 22.02% 22.19% 23.51% 24.35%
EBITDA Margin		 5.64% 8.38% 10.39% 0.65% 5.33% 6.97% 4.94% 7.34% 7.38% 8.21% 9.79%
Operating Margin		 4.61% 7.33% 8.55% 0.07% 2.24% 5.96% 3.77% 6.15% 6.42% 6.97% 8.45%
EBIT Margin		 4.77% 7.38% 9.46% -0.33% 4.16% 5.84% 3.89% 6.34% 6.31% 7.02% 8.46%
Profit (Net Income) Margin		 2.53% 4.00% 5.26% -1.11% 1.58% 3.00% 2.22% 3.89% 3.89% 4.40% 5.68%
Tax Burden Percent		 72.74% 69.34% 67.26% 88.10% 48.16% 59.14% 66.42% 64.83% 68.59% 68.87% 70.93%
Interest Burden Percent		 72.84% 78.16% 82.60% 387.54% 78.85% 86.81% 86.09% 94.75% 89.95% 91.01% 94.65%
Effective Tax Rate		 27.26% 30.66% 32.74% 0.00% 51.84% 40.86% 33.58% 35.17% 31.41% 31.13% 29.07%
Return on Invested Capital (ROIC)		 0.00% 20.78% 0.00% 0.00% 0.00% 14.92% 0.00% 0.00% 0.00% 24.53% 33.22%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 19.38% 0.00% 0.00% 0.00% 12.37% 0.00% 0.00% 0.00% 21.84% 27.69%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 125.60% 0.00% 0.00% 0.00% 4.33% 0.00% 0.00% 0.00% 5.27% 2.49%
Return on Equity (ROE)		 0.00% 146.38% 0.00% 0.00% 0.00% 19.25% 0.00% 0.00% 0.00% 29.80% 35.71%
Cash Return on Invested Capital (CROIC)		 0.00% -80.41% 0.00% 0.00% 0.00% -14.28% -5.09% 0.00% 0.00% 6.72% 4.80%
Operating Return on Assets (OROA)		 0.00% 6.54% 0.00% 0.00% 0.00% 5.45% 0.00% 0.00% 0.00% 6.86% 8.24%
Return on Assets (ROA)		 0.00% 3.54% 0.00% 0.00% 0.00% 2.80% 0.00% 0.00% 0.00% 4.30% 5.53%
Return on Common Equity (ROCE)		 0.00% 138.32% 0.00% 0.00% 0.00% 18.97% 0.00% 0.00% 0.00% 29.59% 35.49%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 26 43 54 0.50 11 43 32 52 59 65 85
NOPAT Margin		 3.36% 5.08% 5.75% 0.05% 1.08% 3.52% 2.50% 3.99% 4.40% 4.80% 5.99%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.40% 1.32% 5.46% 0.00% 2.55% 0.87% 0.46% -596.10% 2.70% 5.52%
Return On Investment Capital (ROIC_SIMPLE)		 - 5.20% - - - 3.79% 2.76% 4.31% 4.81% 5.01% 6.38%
Cost of Revenue to Revenue		 80.91% 79.66% 78.74% 77.62% 82.78% 78.60% 80.16% 77.98% 77.81% 76.49% 75.65%
SG&A Expenses to Revenue		 6.28% 4.92% 5.02% 14.71% 6.88% 7.42% 7.73% 7.66% 7.63% 8.36% 7.91%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 14.48% 13.01% 12.71% 22.30% 14.98% 15.44% 16.07% 15.88% 15.77% 16.53% 15.90%
Earnings before Interest and Taxes (EBIT)		 38 63 88 -3.20 43 70 50 83 85 95 120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 45 72 97 6.36 55 84 63 96 99 112 139
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 4.68 3.52 1.27 0.00 2.82 2.28 2.44 2.40 6.35 4.87
Price to Tangible Book Value (P/TBV)		 0.00 14.59 7.18 1.43 0.00 3.11 2.51 2.66 2.60 6.84 5.21
Price to Revenue (P/Rev)		 0.00 0.14 0.00 0.00 0.00 0.49 0.00 0.00 0.00 1.14 0.93
Price to Earnings (P/E)		 0.00 3.99 0.00 0.00 0.00 35.83 0.00 0.00 0.00 31.39 20.71
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 25.08% 0.00% 0.00% 0.00% 2.79% 0.00% 0.00% 0.00% 3.19% 4.83%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.47 1.38 1.16 0.00 2.33 2.10 2.27 2.40 5.59 4.69
Enterprise Value to Revenue (EV/Rev)		 0.00 0.36 0.00 0.00 0.00 0.55 0.00 0.00 0.00 1.17 0.94
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 4.67 0.00 0.00 0.00 11.88 0.00 0.00 0.00 16.60 11.39
Enterprise Value to EBIT (EV/EBIT)		 0.00 5.38 0.00 0.00 0.00 15.45 0.00 0.00 0.00 19.73 13.30
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 7.48 0.00 0.00 0.00 33.61 0.00 0.00 0.00 29.61 19.49
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 17.50 0.00 0.00 0.00 6.14 0.00 0.00 0.00 15.26 10.40
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.73 108.47
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 7.20 5.87 0.85 0.00 0.57 0.53 0.49 0.40 0.37 0.28
Long-Term Debt to Equity		 0.00 7.04 5.75 0.82 0.00 0.35 0.33 0.30 0.28 0.36 0.27
Financial Leverage		 0.00 6.48 5.27 0.72 0.00 0.35 0.94 0.39 0.00 0.24 0.09
Leverage Ratio		 0.00 34.53 28.94 6.74 0.00 10.71 10.68 6.96 6.42 6.49 6.20
Compound Leverage Factor		 0.00 26.99 23.90 26.11 0.00 9.30 9.20 6.59 5.77 5.91 5.87
Debt to Total Capital		 0.00% 87.81% 85.45% 45.91% 0.00% 36.30% 34.82% 32.94% 28.72% 26.83% 21.96%
Short-Term Debt to Total Capital		 0.00% 2.02% 1.83% 1.47% 0.00% 13.96% 13.35% 12.56% 8.74% 0.34% 0.63%
Long-Term Debt to Total Capital		 0.00% 85.79% 83.62% 44.44% 0.00% 22.34% 21.47% 20.38% 19.99% 26.49% 21.33%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.67% 0.61% 0.57% 0.00% 0.55% 0.52% 0.48% 0.45% 0.44% 0.38%
Common Equity to Total Capital		 0.00% 11.52% 13.94% 53.52% 0.00% 63.15% 64.66% 66.58% 70.82% 72.73% 77.67%
Debt to EBITDA		 0.00 3.07 0.00 0.00 0.00 2.15 0.00 0.00 0.00 0.94 0.66
Net Debt to EBITDA		 0.00 2.76 0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.41 0.10
Long-Term Debt to EBITDA		 0.00 3.00 0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.93 0.64
Debt to NOPAT		 0.00 4.91 0.00 0.00 0.00 6.08 0.00 0.00 0.00 1.68 1.12
Net Debt to NOPAT		 0.00 4.42 0.00 0.00 0.00 3.73 0.00 0.00 0.00 0.73 0.17
Long-Term Debt to NOPAT		 0.00 4.80 0.00 0.00 0.00 3.74 0.00 0.00 0.00 1.65 1.09
Altman Z-Score		 0.00 1.15 0.29 0.27 0.00 1.11 0.28 0.00 0.00 1.87 1.78
Noncontrolling Interest Sharing Ratio		 0.00% 5.51% 4.19% 1.06% 0.00% 1.44% 1.35% 0.00% 0.00% 0.71% 0.62%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.58 1.56 1.71 0.00 0.96 0.98 0.92 0.94 1.07 1.00
Quick Ratio		 0.00 1.47 1.45 1.57 0.00 0.89 0.93 0.84 0.88 0.90 0.91
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -783 -995 0.00 0.00 -11 102 -815 -74 -129
Operating Cash Flow to CapEx		 32.99% -16.78% 65.86% 31.23% 324.81% 77.66% 848.02% 0.00% 0.00% -2.99% 218.13%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -50.89 -108.33 0.00 0.00 -1.64 23.36 -95.61 -8.59 -20.15
Operating Cash Flow to Interest Expense		 1.49 -0.71 3.82 3.79 23.16 6.94 21.76 0.00 0.00 -0.40 36.79
Operating Cash Flow Less CapEx to Interest Expense		 -3.02 -4.91 -1.98 -8.35 16.03 -2.00 19.20 0.00 0.00 -13.63 19.92
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.89 0.00 0.00 0.00 0.93 0.00 0.00 0.00 0.98 0.97
Accounts Receivable Turnover		 0.00 5.19 0.00 0.00 0.00 6.21 0.00 0.00 0.00 7.46 7.37
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 5.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.83 4.71
Accounts Payable Turnover		 0.00 17.37 0.00 0.00 0.00 20.87 0.00 0.00 0.00 22.49 22.04
Days Sales Outstanding (DSO)		 0.00 70.39 0.00 0.00 0.00 58.75 0.00 0.00 0.00 48.95 49.55
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 21.02 0.00 0.00 0.00 17.49 0.00 0.00 0.00 16.23 16.56
Cash Conversion Cycle (CCC)		 0.00 49.37 0.00 0.00 0.00 41.26 0.00 0.00 0.00 32.72 32.99
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 761 837 996 0.00 966 873 918 875 1,105 1,087
Invested Capital Turnover		 0.00 4.09 0.00 0.00 0.00 4.23 0.00 0.00 0.00 5.11 5.54
Increase / (Decrease) in Invested Capital		 0.00 0.00 837 996 0.00 0.00 43 -50 875 139 215
Enterprise Value (EV)		 0.00 1,115 1,159 1,151 0.00 2,254 1,836 2,080 2,096 6,170 5,098
Market Capitalization		 450 450 450 727 6,091 1,998 1,713 1,969 2,092 6,012 5,048
Book Value per Share		 $0.00 $0.75 $0.99 $3.83 $0.00 $4.66 $4.92 $5.29 $5.72 $6.05 $6.60
Tangible Book Value per Share		 $0.00 $0.24 $0.49 $3.39 $0.00 $4.22 $4.48 $4.85 $5.27 $5.61 $6.17
Total Capital		 0.00 834 918 1,069 0.00 1,124 1,160 1,212 1,230 1,302 1,335
Total Debt		 0.00 733 785 491 0.00 408 404 399 353 349 293
Total Long-Term Debt		 0.00 716 768 475 0.00 251 249 247 246 345 285
Net Debt		 0.00 659 703 417 0.00 250 117 105 -2.30 152 45
Capital Expenditures (CapEx)		 46 58 89 111 64 83 18 0.00 0.00 114 108
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 209 236 275 0.00 -41 -159 -232 -319 -124 -245
Debt-free Net Working Capital (DFNWC)		 0.00 282 317 348 0.00 117 129 62 37 73 2.97
Net Working Capital (NWC)		 0.00 265 300 333 0.00 -40 -26 -90 -71 68 -5.42
Net Nonoperating Expense (NNE)		 6.55 9.22 4.64 11 -5.15 6.38 3.59 1.22 6.84 5.42 4.47
Net Nonoperating Obligations (NNO)		 0.00 659 703 417 0.00 250 117 105 -2.30 152 45
Total Depreciation and Amortization (D&A)		 6.91 8.52 8.68 9.55 12 14 13 13 14 16 19
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 6.71% 0.00% 0.00% 0.00% -1.00% 0.00% 0.00% 0.00% -2.35% -4.51%
Debt-free Net Working Capital to Revenue		 0.00% 9.06% 0.00% 0.00% 0.00% 2.85% 0.00% 0.00% 0.00% 1.38% 0.05%
Net Working Capital to Revenue		 0.00% 8.52% 0.00% 0.00% 0.00% -0.98% 0.00% 0.00% 0.00% 1.29% -0.10%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.28 $0.38 ($0.07) $0.00 $0.22 $0.18 $0.33 $0.33 $0.39 $0.51
Adjusted Weighted Average Basic Shares Outstanding		 0.00 128.72M 128.72M 149.46M 0.00 146.66M 155.18M 156.34M 156.58M 156.18M 157.07M
Adjusted Diluted Earnings per Share		 $0.00 $0.28 $0.38 ($0.07) $0.00 $0.22 $0.17 $0.31 $0.32 $0.42 $0.50
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 128.72M 128.72M 149.46M 0.00 148.57M 166.42M 165.47M 164.71M 156.70M 162.08M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 24.64M 152.40M 0.00 0.00 0.00 0.00 156.62M 157.17M 158.27M
Normalized Net Operating Profit after Tax (NOPAT)		 26 43 54 0.50 16 43 32 52 59 65 85
Normalized NOPAT Margin		 3.36% 5.08% 5.75% 0.05% 1.57% 3.52% 2.50% 3.99% 4.40% 4.80% 5.99%
Pre Tax Income Margin		 3.47% 5.77% 7.82% -1.26% 3.28% 5.07% 3.35% 6.00% 5.67% 6.39% 8.01%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.68 4.58 5.75 -0.35 4.73 7.58 7.19 19.06 9.95 11.12 18.70
NOPAT to Interest Expense		 2.59 3.15 3.49 0.05 1.23 4.58 4.63 11.99 6.94 7.60 13.25
EBIT Less CapEx to Interest Expense		 -0.82 0.38 -0.05 -12.48 -2.40 -1.36 4.62 0.00 0.00 -2.11 1.84
NOPAT Less CapEx to Interest Expense		 -1.91 -1.05 -2.31 -12.08 -5.91 -4.37 2.06 0.00 0.00 -5.63 -3.61
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 71.22% 0.00% 0.00% 0.00% 60.93% 0.00% 0.00% 0.00% 0.20% 0.24%
Augmented Payout Ratio		 0.00% 71.22% 0.00% 0.00% 0.00% 60.93% 0.00% 0.00% 0.00% 0.20% 0.24%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor-focused trend analysis of PACS Group (NYSE:PACS) using the latest quarterly data across 2021–2025, with a focus on the four most recent years of statements (Q1–Q4 2025, plus representative prior quarters for context). The highlights below point to where the company has shown strength, as well as where it faces ongoing leverage and cash-flow challenges.

  • Revenue momentum: Operating revenue increased across 2025, finishing Q4 2025 at 1,357,979,000 USD, up from 1,207,888,000 USD in Q4 2024 (and higher than each prior quarter in 2025: Q1 1.277B, Q2 1.309B, Q3 1.344B).
  • Gross margin improvement: Gross profit for Q4 2025 was 319,215,000 USD on 1,357,979,000 USD of revenue, about a 23.5% gross margin, up from roughly 21.4% in Q4 2024 (258,535,000 USD gross profit on 1,207,888,000 USD revenue).
  • Earnings per share and net income to shareholders improving: Q4 2025 net income attributable to common shareholders was 59,702,000 USD, with diluted earnings per share of 0.42 USD and basic of 0.39 USD, up from Q4 2024 levels (net income to common around 37,201,000 USD; diluted EPS ~0.32 USD; basic ~0.22 USD).
  • Operating income strengthened: Q4 2025 total operating income reached 94,687,000 USD, up from 61,198,000 USD in Q4 2024, indicating improved operating profitability despite higher costs.
  • Debt and equity structure: Total liabilities remained high relative to equity in 2025 (Total Liabilities around 4.75B USD vs. Total Equity & Noncontrolling Interests around 0.88B USD in Q3 2025), signaling a levered balance sheet but a relatively modest equity base to absorb shocks.
  • Debt load and stability: Long-term debt hovered around 246M USD across 2025 (e.g., 246.99M in Q2 2025 and 245.90M in Q3 2025), showing little year-over-year change in base debt level.
  • Liquidity snapshot: Cash & equivalents were about 355.7M USD at the Q3 2025 balance sheet, with cash balances fluctuating across quarters; this provides a moderate liquidity cushion but must be watched given cash-flow dynamics.
  • Near-term cash flow pressure: For Q4 2025, cash flow from continuing operating activities was negative (-3,390,000 USD), even as earnings rose, suggesting working-capital and non-cash adjustments are pressure points.
  • Cash burn in the quarter: Net change in cash and equivalents for Q4 2025 was -127,005,000 USD, indicating a meaningful quarterly cash outflow notwithstanding higher profits.
  • Financing/capital actions: Net cash from financing activities in Q4 2025 was negative (-5,469,000 USD), implying limited external funding activity or net debt reduction during the quarter.
  • Noncurrent liabilities and related obligations: Other noncurrent liabilities were substantial (about 3.13B USD in the latest period), contributing to a large noncurrent-liability base alongside total noncurrent liabilities (~3.55B USD). This underscores significant long-term obligations relative to current equity, heightening balance-sheet risk.
05/31/26 10:04 PM ETAI Generated. May Contain Errors.

PACS Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PACS Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

PACS Group's net income appears to be on an upward trend, with a most recent value of $191.46 million in 2025, rising from $150.50 million in 2022. The previous period was $55.34 million in 2024. Check out PACS Group's forecast to explore projected trends and price targets.

PACS Group's total operating income in 2025 was $309.60 million, based on the following breakdown:
  • Total Gross Profit: $1.16 billion
  • Total Operating Expenses: $849.64 million

Over the last 3 years, PACS Group's total revenue changed from $2.42 billion in 2022 to $5.29 billion in 2025, a change of 118.4%.

PACS Group's total liabilities were at $4.63 billion at the end of 2025, a 2.3% increase from 2024, and a 35.8% increase since 2023.

In the past 2 years, PACS Group's cash and equivalents has ranged from $73.42 million in 2023 to $197.02 million in 2025, and is currently $197.02 million as of their latest financial filing in 2025.

Over the last 3 years, PACS Group's book value per share changed from 0.00 in 2022 to 6.05 in 2025, a change of 604.5%.


Related Companies

Financial statements for NYSE:PACS last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel